OKYO Pharma Limited Ordinary Shares (OKYO)
Stock · NASDAQ · Health Care
$1.67as of 8/28/2026
Price chart
Open in TradingViewActive signals
Support level
$1.57
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
About OKYO
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunc…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 5
- Website
- okyopharma.com/
Fundamentals
- 1-day range
- $1.51$1.67
- Market cap
- $56.51M
- P/E (trailing)
- —
- P/E (forward)
- -2.53
- EPS (trailing)
- $-0.24
- Dividend yield
- —
- Beta
- 0.07
- Avg. volume
- 99.5K
52-week range
$1.34$3.2
Forecasts
3 analyst ratings
Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$13
+678.4%
Median
$7
+319.2%
Low
$5
+199.4%
OKYO Pharma Limited Ordinary Shares Competitors
Chosen by industry and closest market cap.
- OKYOOKYO Pharma Limited Ordinary Shares$1.67▲ 7.74%Market cap $56.51MP/E —$1.34$3.2
- SCLXScilex Holding Company Common Stock$5.42▼ 2.69%Market cap $55.70MP/E —$4.2$34.27
- INKTMiNK Therapeutics Inc. Common Stock$11.43▼ 2.16%Market cap $53.26MP/E —$8.48$16.98
- XTNTXtant Medical Holdings Inc. Common Stock$0.4055▲ 22.88%Market cap $61.72MP/E 23.84$0.2702$0.95
- IMAImageneBio Inc. Common Stock$5.34▲ 0.19%Market cap $63.61MP/E —$3.94$13.98
- TILInstil Bio Inc. Common Stock$7.58▼ 3.56%Market cap $48.97MP/E —$5.67$33.83
- EXOZeXoZymes Inc. Common Stock$7.17▼ 0.10%Market cap $47.57MP/E —$4.35$18.4
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OKYO OKYO Pharma Limited Ordinary Shares | $56.51M | — | $1.67 | ▲ 7.74% | $1.34$3.2 |
| SCLX Scilex Holding Company Common Stock | $55.70M | — | $5.42 | ▼ 2.69% | $4.2$34.27 |
| INKT MiNK Therapeutics Inc. Common Stock | $53.26M | — | $11.43 | ▼ 2.16% | $8.48$16.98 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $61.72M | 23.84 | $0.4055 | ▲ 22.88% | $0.2702$0.95 |
| IMA ImageneBio Inc. Common Stock | $63.61M | — | $5.34 | ▲ 0.19% | $3.94$13.98 |
| TIL Instil Bio Inc. Common Stock | $48.97M | — | $7.58 | ▼ 3.56% | $5.67$33.83 |
| EXOZ eXoZymes Inc. Common Stock | $47.57M | — | $7.17 | ▼ 0.10% | $4.35$18.4 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →Acquired
228.7K
Disposed
0
- Rajkumar Patil V · July 27, 2026 · Grant3.4K @ $1.49
- Rajkumar Patil V · July 27, 2026 · Buy3.4K @ $1.49
- Robert John Dempsey · July 22, 2026 · Buy15.0K @ $1.54
- Robert John Dempsey · July 22, 2026 · Grant15.0K @ $1.54
- Flavio Mantelli · July 21, 2026 · Buy20.0K @ $1.4
- John P. Brancaccio · July 21, 2026 · Buy5.0K @ $1.48
- Gary S. Jacob · July 21, 2026 · Buy3.5K @ $1.4
- Gabriele M. Cerrone · July 21, 2026 · Buy22.5K @ $1.45
- John P. Brancaccio · July 21, 2026 · Grant5.0K @ $1.48
- Gary S. Jacob · July 21, 2026 · Grant3.5K @ $1.4
- Gabriele M. Cerrone · July 21, 2026 · Grant22.5K @ $1.45
- Flavio Mantelli · July 21, 2026 · Grant20.0K @ $1.4
- Gabriele M. Cerrone · July 20, 2026 · Buy25.0K @ $1.4
- Gabriele M. Cerrone · July 20, 2026 · Grant25.0K @ $1.4
- Shah Keeren Rameshchandra · June 8, 2026 · Grant40.0K @ $1.85
See the full, filterable feed with live charts on the MarketWall dashboard.